 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 2002 | Volume 136 Issue 1 | Pages 54-71
A large body of evidence in animal models of ischemia shows that administration of angiogenic growth factors, either as recombinant protein or by gene transfer, can augment nutrient perfusion through neovascularization. Many cytokines have angiogenic activity; those that have been best studied in animal models and clinical trials are vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). Clinical trials of therapeutic angiogenesis in patients with end-stage coronary artery disease have shown increases in exercise time and reductions in anginal symptoms and have provided objective evidence of improved perfusion and left ventricular function. Larger-scale placebo-controlled trials have been limited to intracoronary and intravenous administration of recombinant protein and have not yet shown significant improvement in exercise time or angina compared with placebo. Larger-scale placebo-controlled studies of gene transfer are in progress.
Clinical studies are required to determine the optimal dose, formulation, route of administration, and combinations of growth factors and the utility of adjunctive endothelial progenitor-cell or stem-cell supplementation, to provide safe and effective therapeutic myocardial angiogenesis. Determination of which growth factors or cells are required to optimize therapeutic neovascularization in an individual patient should be a goal of future research.
Author and Article Information
From St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts, and Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.
Note: Jeffrey Isner, MD, died suddenly during the preparation of proofs of the manuscript.
Acknowledgments: The authors thank Rene Tio, MD, James F. Symes, MD, Peter R. Vale, MD, Douglas W. Losordo, MD, and Charles Milliken, BS, MS, who contributed to several of the studies summarized in this paper, and Mrs. Mickey Neely for preparation of the manuscript.
Requests for Single Reprints: Mickey Neely, St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135; e-mail, mneely222{at}aol.com.
Current Author Addresses: Dr. Freedman: Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Hospital Road, Concord, New South Wales 2139, Australia. REVIEW
Therapeutic Angiogenesis for Coronary Artery Disease
Deceased.
This article has been cited by other articles:
|
|
 |
|
  H. Leong-Poi, M. A. Kuliszewski, M. Lekas, M. Sibbald, K. Teichert-Kuliszewska, A. L. Klibanov, D. J. Stewart, and J. R. Lindner Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle Circ. Res., August 3, 2007; 101(3): 295 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Grote, G. Salguero, M. Ballmaier, M. Dangers, H. Drexler, and B. Schieffer The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration Blood, August 1, 2007; 110(3): 877 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iwasaki, K. Fukushima, A. Kawamoto, K. Umetani, A. Oyamada, S. Hayashi, T. Matsumoto, M. Ishikawa, T. Shibata, H. Nishimura, et al. Synchrotron Radiation Coronary Microangiography for Morphometric and Physiological Evaluation of Myocardial Neovascularization Induced by Endothelial Progenitor Cell Transplantation Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Saeed, D. Saloner, A. Martin, L. Do, O. Weber, P. C. Ursell, A. Jacquier, R. Lee, and C. B. Higgins Adeno-associated Viral Vector-Encoding Vascular Endothelial Growth Factor Gene: Effect on Cardiovascular MR Perfusion and Infarct Resorption Measurements in Swine Radiology, May 1, 2007; 243(2): 451 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Retuerto, J. T. Beckmann, J. Carbray, G. Patejunas, S. Sarateanu, B. J. Kane, B. Smulevitz, D. D. McPherson, and T. K. Rosengart Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 478 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caligiuri, S. V. Kaveri, and A. Nicoletti IL-20 and Atherosclerosis: Another Brick In the Wall. Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1929 - 1930. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kodama, Y. Kitta, T. Nakamura, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, A. Mende, et al. Atorvastatin Increases Plasma Soluble Fms-Like Tyrosine Kinase-1 and Decreases Vascular Endothelial Growth Factor and Placental Growth Factor in Association With Improvement of Ventricular Function in Acute Myocardial Infarction J. Am. Coll. Cardiol., July 4, 2006; 48(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chareonthaitawee, S. D. Christenson, J. L. Anderson, B. J. Kemp, D. O. Hodge, E. L. Ritman, and R. J. Gibbons Reproducibility of Measurements of Regional Myocardial Blood Flow in a Model of Coronary Artery Disease: Comparison of H215O and 13NH3 PET Techniques J. Nucl. Med., July 1, 2006; 47(7): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yoon, J. Hur, I.-Y. Oh, K.-W. Park, T.-Y. Kim, J.-H. Shin, J.-H. Kim, C.-S. Lee, J.-K. Chung, Y.-B. Park, et al. Intercellular Adhesion Molecule-1 Is Upregulated in Ischemic Muscle, Which Mediates Trafficking of Endothelial Progenitor Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1066 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Oltmanns, H. Gehring, S. Rudolf, B. Schultes, C. Hackenberg, U. Schweiger, J. Born, H. L. Fehm, and A. Peters Acute hypoxia decreases plasma VEGF concentration in healthy humans Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E434 - E439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Glod, D. Kobiler, M. Noel, R. Koneru, S. Lehrer, D. Medina, D. Maric, and H. A. Fine Monocytes form a vascular barrier and participate in vessel repair after brain injury Blood, February 1, 2006; 107(3): 940 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Sarateanu, M. A. Retuerto, J. T. Beckmann, L. McGregor, J. Carbray, G. Patejunas, L. Nayak, J. Milbrandt, and T. K. Rosengart An Egr-1 master switch for arteriogenesis: Studies in Egr-1 homozygous negative and wild-type animals J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 138 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakagami, K. Maeda, R. Morishita, S. Iguchi, T. Nishikawa, Y. Takami, Y. Kikuchi, Y. Saito, K. Tamai, T. Ogihara, et al. Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-Derived Stromal Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2542 - 2547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hou, E. A.-S. Youssef, T. J. Brinton, P. Zhang, P. Rogers, E. T. Price, A. C. Yeung, B. H. Johnstone, P. G. Yock, and K. L. March Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery: Implications for Current Clinical Trials Circulation, August 30, 2005; 112(9_suppl): I-150 - I-156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Amano, N. R. Hackett, S. Rafii, and R. G. Crystal Thrombopoietin Gene Transfer-Mediated Enhancement of Angiogenic Responses to Acute Ischemia Circ. Res., August 19, 2005; 97(4): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leong-Poi, J. Christiansen, P. Heppner, C. W. Lewis, A. L. Klibanov, S. Kaul, and J. R. Lindner Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression Circulation, June 21, 2005; 111(24): 3248 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn Vascular Endothelial Growth Factor and Angiogenesis Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Werner, E. Jandt, A. Krack, G. Schwarz, O. Mutschke, F. Kuethe, M. Ferrari, and H. R. Figulla Growth Factors in the Collateral Circulation of Chronic Total Coronary Occlusions: Relation to Duration of Occlusion and Collateral Function Circulation, October 5, 2004; 110(14): 1940 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schalch, G. Patejunas, M. Retuerto, S. Sarateanu, J. Milbrandt, G. Thakker, D. Kim, J. Carbray, R. G. Crystal, and T. K. Rosengart Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: Evidence for a central role in vascular homeostasis J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raake, G. von Degenfeld, R. Hinkel, R. Vachenauer, T. Sandner, S. Beller, M. Andrees, C. Kupatt, G. Schuler, and P. Boekstegers Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1124 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Weber, I. Pedrosa, A. Kawamoto, N. Himes, J. Munasinghe, T. Asahara, N. M. Rofsky, and D. W. Losordo Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 137 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Askari, S. Unzek, C. K. Goldman, S. G. Ellis, J. D. Thomas, P. E. DiCorleto, E. J. Topol, and M. S. Penn Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1908 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hilfiker-Kleiner, K. Kaminski, A. Kaminska, M. Fuchs, G. Klein, E. Podewski, K. Grote, I. Kiian, K. C. Wollert, A. Hilfiker, et al. Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation Circulation, May 11, 2004; 109(18): 2227 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen Collateralization and the response to obstruction of epicardial coronary arteries QJM, May 1, 2004; 97(5): 259 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Panchal, J. Rehman, A. T. Nguyen, J. W. Brown, M. W. Turrentine, Y. Mahomed, and K. L. March Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1383 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Ashton, Y. Cheng, A. Helisch, and J. A. Ware Thromboxane A2 Receptor Agonists Antagonize the Proangiogenic Effects of Fibroblast Growth Factor-2: Role of Receptor Internalization, Thrombospondin-1, and {alpha}v{beta}3 Circ. Res., April 2, 2004; 94(6): 735 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Retuerto, P. Schalch, G. Patejunas, J. Carbray, N. Liu, K. Esser, R. G. Crystal, and T. K. Rosengart Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1041 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rehman, D. Traktuev, J. Li, S. Merfeld-Clauss, C. J. Temm-Grove, J. E. Bovenkerk, C. L. Pell, B. H. Johnstone, R. V. Considine, and K. L. March Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells Circulation, March 16, 2004; 109(10): 1292 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Svorkdal Treatment of Inoperable Coronary Disease and Refractory Angina: Spinal Stimulators, Epidurals, Gene Therapy, Transmyocardial Laser, and Counterpulsation Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 43 - 58. [Abstract] [PDF]
|
|
|
|
|
|
N. P. Fam, S. Verma, M. Kutryk, and D. J. Stewart Clinician Guide to Angiogenesis Circulation, November 25, 2003; 108(21): 2613 - 2618. [Full Text] [PDF]
|
|
|
|
|
|
G. von Degenfeld, P. Raake, C. Kupatt, C. Lebherz, R. Hinkel, F. J. Gildehaus, W. Munzing, A. Kranz, J. Waltenberger, M. Simoes, et al. Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1120 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lu, W. R. Wagner, U. Schellenberger, J. A. Abraham, A. L. Klibanov, S. R. Woulfe, M. M. Csikari, D. Fischer, G. F. Schreiner, G. H. Brandenburger, et al. Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor: Approach to Identification of Ischemic Tissue Circulation, July 8, 2003; 108(1): 97 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O. Bonetti, D. R. Holmes Jr, A. Lerman, and G. W. Barsness Enhanced external counterpulsation for ischemic heart disease: What's behind the curtain? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1918 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]
|
|
|
|
|
|
E. C. Perin, G. V. Silva, R. Sarmento-Leite, A. L.S. Sousa, M. Howell, R. Muthupillai, B. Lambert, W. K. Vaughn, and S. D. Flamm Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery Disease: Validation by Delayed-Enhancement Magnetic Resonance Imaging Circulation, August 20, 2002; 106(8): 957 - 961. [Abstract] [Full Text] [PDF]
|
|
Article
